Financial Ratios

ALEMBIC LTD.

NSE : ALEMBICLTDBSE : 506235ISIN CODE : INE426A01027Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE83.663.48 (+4.34 %)
PREV CLOSE ( ) 80.18
OPEN PRICE ( ) 80.19
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 82234
TODAY'S LOW / HIGH ( )80.19 84.20
52 WK LOW / HIGH ( )55.52 107.5
NSE83.453.1 (+3.86 %)
PREV CLOSE( ) 80.35
OPEN PRICE ( ) 80.95
BID PRICE (QTY) 83.45 (5)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1158434
TODAY'S LOW / HIGH( ) 80.90 84.40
52 WK LOW / HIGH ( )55.45 107.65
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)3.093.340.523.641.60
   CEPS(Rs)3.333.510.673.771.70
   DPS(Rs)2.201.800.200.600.20
   Book NAV/Share(Rs)32.2839.4832.2018.8116.06
   Tax Rate(%)6.7411.8919.100.148.03
Margin Ratios
   Core EBITDA Margin(%)30.8617.0013.954.8614.04
   EBIT Margin(%)69.14128.3523.22127.5136.28
   Pre Tax Margin(%)69.01128.0422.85127.1336.10
   PAT Margin (%)64.36112.8218.48126.9633.20
   Cash Profit Margin (%)69.53118.7523.89131.3335.32
Performance Ratios
   ROA(%)7.588.241.8218.648.29
   ROE(%)8.609.312.0420.899.55
   ROCE(%)9.2410.592.5620.9810.43
   Asset Turnover(x)0.120.070.100.150.25
   Sales/Fixed Asset(x)0.810.500.490.420.86
   Working Capital/Sales(x)1.431.041.750.632.48
Efficiency Ratios
   Fixed Capital/Sales(x)1.231.982.042.361.17
   Receivable days55.6967.2655.5255.4857.19
   Inventory Days260.04339.07226.41175.2099.84
   Payable days161.20294.16248.85217.20112.21
Valuation Parameters
   PER(x)19.2121.67197.649.8026.39
   PCE(x)17.7820.59152.889.4724.81
   Price/Book(x)1.841.833.191.902.63
   Yield(%)3.712.490.191.680.47
   EV/Net Sales(x)12.3524.4336.4411.668.75
   EV/Core EBITDA(x)14.8918.20127.318.8422.78
   EV/EBIT(x)17.8619.04156.979.1424.11
   EV/CE(x)1.601.622.811.612.31
   M Cap / Sales12.3624.4536.5312.448.76
Growth Ratio
   Net Sales Growth(%)62.115.08-1.89-40.48-1.19
   Core EBITDA Growth(%)0.11392.87-78.70104.43-1.20
   EBIT Growth(%)-12.67480.92-82.14109.211.29
   PAT Growth(%)-7.52541.39-85.71127.59-1.61
   EPS Growth(%)-7.52541.43-85.72127.592.31
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)2.062.101.713.592.02
   Quick Ratio(x)0.970.800.782.811.30
   Interest Cover(x)545.84423.5863.01337.75207.74
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.